12:00 AM
Aug 06, 2007
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Chronocort: Phase III start

In 1Q08, PQS expects to begin an open-label, European and U.S. Phase III trial (Study 005) in about 60 to evaluate...

Read the full 84 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >